Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis
Clinical trial NCT03760003 · COMPLETED
Trial details
- NCT number
- NCT03760003
- Sponsor
- Abivax S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-13
- Primary completion
- 2021-04-01
- Enrollment
- 355
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.